Quarterly report pursuant to Section 13 or 15(d)

Schedule of Incurred Expenses of Minority Shareholders (Details)

v3.23.1
Schedule of Incurred Expenses of Minority Shareholders (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Cost and Expense, Related and Nonrelated Party Status [Extensible Enumeration] us-gaap:RelatedPartyMember us-gaap:RelatedPartyMember
Total Related Party Expenses $ 646 $ 338
Royalty [Member]    
CWRU – Royalty Fees 24 9
General and Administrative Expense [Member]    
Stock-based compensation expense – Physician Inventors’ stock options 180 272
Research and Development Expense [Member]    
Stock-based compensation expense – Physician Inventors’ stock options 52 46
Amended CWRU – License Agreement - reimbursement of patent legal fees 389
Fees - Physician Inventors’ consulting agreements 1 8
Sponsored research agreement $ 3